SHINE Technologies key facts
as of Oct 2026- Developer of fusion-based technology solutions that produce neutron sources for industrial imaging applications, including neutron radiography, radiation-effects testing, and fusion material…
- SHINE Technologies is valued at approximately $368.1M as of Oct 2026 (last reported valuation).
- It has raised $1.0B across 2 recorded rounds; the latest was PE Growth/Expansion ($138.4M) in Oct 2023.
- Notable investors include Alumni Ventures, Fidelity Management & Research Company, U.S. Department of Energy, Baillie Gifford, Koch Disruptive Technologies — 24 tracked in total.
- Status: Privately Held (backing).
SHINE Technologies's last reported valuation, Jun 2019. Nothing priced has surfaced since.
- ·The complete investor list: 24 names
- ·Watch SHINE Technologies: the Monday email on marks, rounds and moves
SHINE Technologies funding rounds
2 roundsWho backs SHINE Technologies
24+SHINE Technologies valuation
SHINE Technologies's last reported valuation was $368 million in Jun 2019. No priced round, secondary trade or fund mark has surfaced since.
How much has SHINE Technologies raised?
SHINE Technologies has raised $1 billion in total; 2 of its rounds are on record. The largest on record was a $150 million growth round in Jun 2021; the most recent was a $138 million growth round in Oct 2023.
SHINE Technologies investors
24 investors are on record for SHINE Technologies, including Alumni Ventures, Fidelity Management & Research Company, U.S. Department of Energy and Baillie Gifford. By type, the record holds 4 venture capital firms and 2 asset managers. The growth round in Oct 2023 drew 1 investor.
About SHINE Technologies
Developer of fusion-based technology solutions that produce neutron sources for industrial imaging applications, including neutron radiography, radiation-effects testing, and fusion material research, and is developing technology for nuclear waste recycling. The company produces medical isotopes using fusion-based neutron sources and manufactures medical isotopes, including lutetium-177, for diagnostic and therapeutic applications.
- Industry
- Pharmaceuticals
- Sector
- Healthcare
- HQ
- Janesville, WI, United States
- Founded
- 2010
- Employees
- 400
- Website
- shinefusion.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.